Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model

doi:10.4254/wjh.v11.i4.359

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12148)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

599

WORD

272

HTML

5769

Figures (1-4)

437

Tables (1-2)

310

Sum=7387

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

639

Download

1251

Sum=1890

Publishing Process of This Article

Item

Count

Browse

960

Download

1911

Sum=2871

Apr 27, 2019 (publication date) through Jan 31, 2025

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Apr 27, 2019; 11(4): 359-369
Published online Apr 27, 2019. doi: 10.4254/wjh.v11.i4.359

Table 1 Forward and reverse sequences of RT-qPCR primers

Primers
Gene	5’- 3’	3’-5’
Renin	ACCTTGCTTGTGGGATTCAC	CCTGATCCGTAGTGGATGGT
ACE1	GTGGCTGGAAGAGCAGAATC	GCCTTGGCTTCATCAGTCTC
ACE2	CAACAGAAGCCAGACAACA	GCCTTGGCTTCATCAGTCTC
AT1r	CCCTGGCTGACTTATGCTTT	ACATAGGTGATTGCCGAAGG
AT2r	GAAGCTCCGCAGTGTGTTTA	TGGCTAGGCTGATTACATGC
rMAS	TTCTCCACCATCAACAGCAG	CCTGGGTTGCATTTCATCTT
B-actin	TGTTACCAACTGGGACGACA	GGGGTGTTGAAGGTCTCAAA

ACE1: Angiotensin-converting enzyme; ACE2: Angiotensin-converting enzyme 2; AT1r: Angiotensin type-1 receptor; AT2r: Angiotensin type-2 receptor; rMAS: MAS receptor.

Citation: Graus-Nunes F, Santos FO, Marinho TS, Miranda CS, Barbosa-da-Silva S, Souza-Mello V. Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model. World J Hepatol 2019; 11(4): 359-369
URL: https://www.wjgnet.com/1948-5182/full/v11/i4/359.htm
DOI: https://dx.doi.org/10.4254/wjh.v11.i4.359